Tezspire Cardiac Events PASS

Trial Identifier:	D5180R00024
Sponsor:	AstraZeneca
Collaborator:	IQVIA Ltd.
Start Date:	September 2025
Primary Completion Date:	May 2029
Study Completion Date:	May 2029
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.